Advanced Search

 

Study ID Status Title Patient Level Data
117006 Completed Drug Treatment Patterns and Survival Among Patients with Metastatic or Recurrent Soft Tissue Sarcoma (m/rSTS) Refractory to at Least One Prior Therapy
117008 Completed An Open Label, Non-Randomized, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Placebo-Controlled, Randomized Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
117009 Completed A Study to Evaluate the Effect of GSK1265744 150mg Administered Orally Every 12h x 3 Doses on Cardiac Conduction as Assessed by 12-lead Electrocardiogram Compared to Placebo and a Single Oral Dose of Moxifloxacin
117010 Completed Phase I, single-center, open label, fixed-sequence cross-over study to evaluate the effect of rifampin on the pharmacokinetics of oral cabotegravir in healthy subjects
117011 Completed An Open-label Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol when Co-administered with GSK1265744 in Healthy Adult Female Subjects
117012 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparations of chewable tablets of Montelukast 5 mg (product of GlaxoSmithKline México, S.A. de C.V. vs. Singulair™, Merck Sharp & Dohme de México, S.A. de C.V.) in fasting healthy volunteers
117014 Completed Efficacy, safety and immunogenicity study of GSK Biologicals’ candidate malaria vaccine 257049 in the sporozoite challenge model in healthy malaria-naïve adults Study Listed on ClinicalStudyDataRequest.com
117015 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparations containing Montelukast 10 mg (product of GlaxoSmithKline México, S.A. de C.V. vs. Singulair, Merck Sharp & Dohme de México, S.A. de C.V.)in fasting healthy volunteers
117016 Completed An Open Label Study in Healthy Volunteers to Investigate the Effect of Ketoconazole on the Pharmacokinetics of GSK239512 Study Listed on ClinicalStudyDataRequest.com
117017 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparations containing Nimesulide 100 mg(Eskaflam®, GlaxoSmithKline México, S.A. de C.V. vs. Mesulid®, Producto de Roche, S.A. de C.V.) in fasting healthy volunteers
117019 Recruiting A Phase II, Open-label, Study in Subjects with BRAF V600E-Mutated Rare Cancers with Several Histologies to Investigate the Clinical Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib
117020 Completed A Two Part, Single-center, Randomized, Open-label, Crossover Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects
117023 Completed A Study to Evaluate the Effect of Age, Food and Gender on Tolerability and Pharmacokinetics of GSK2256294 Following a Single Oral Administration in Healthy Fed and Fasted Elderly Subjects. This Study will also Evaluate the Biliary Metabolites in Healthy Young Males Following a Single Dose of GSK2256294 Study Listed on ClinicalStudyDataRequest.com
117036 Completed Immunogenicity and safety study of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A when co-administered with GSK Biologicals’ seasonal influenza vaccine GSK2321138A in adults aged 50 years and older
117041 Completed A Phase 1, Open-Label, Randomized, Controlled, Four-Period Crossover Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers Study Listed on ClinicalStudyDataRequest.com
117044 Completed Efficacy, safety and tolerability of amoxicillin + clavulanic acid (875mg/125mg) two times a day compared to clindamycin (150mg) four times a day for 5-7 days in treatment of acute odontogenic infection with or without abscess Study Listed on ClinicalStudyDataRequest.com
117047 Recruiting Epidemiological Multinational (Russian Federation, Ukraine, Republic of Kazakhstan) Chronic Lymphocytic Leukemia Retrospective Observational Study (LEUKOSPECT) to Evaluate Medical, Economic and Social Factors in Patients with Chronic Lymphocytic Leukemia.
117049 Withdrawn Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome patients: An open-label, randomized, add-on study
117051 Completed WEUSKOP6166: Prevalence of Aseptic Meningitis among Lamotrigine users
117057 Completed An Open-label, Randomized, Single Dose, three-way Crossover study to determine the Bioavailability of Two Fixed Dose Combination Capsule Formulations of Dutasteride and Tamsulosin Hydrochloride (0.5mg/0.2mg) Relative to Co-administration of Dutasteride 0.5mg capsules and Tamsulosin Hydrochloride 0.2mg tablets in Healthy Male Subjects in the fed and fasted states
117058 Completed A Four Way Crossover Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies
117059 Terminated OPV117059: A Long-Term Extension Study of Ofatumumab Injection for Subcutaneous Use in Subjects with Pemphigus Vulgaris
117084 Completed Latin America Observational Study on Epilepsy Patients
117099 Withdrawn Immunogenicity and safety study of GSK Biologicals’ human papillomavirus (HPV) vaccine (Cervarix™) (GSK-580299) when co-administered with GSK Biologicals’ hepatitis A vaccine (Havrix®) (GSK-208109) in healthy female adolescents aged 9–14 years
117100 Completed A Randomized, Parallel-Group, Open-Label Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Administered Subcutaneously to Healthy Subjects by Prefilled Syringe or Autoinjector Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.